Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new LX-101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results